CL2013002024A1 - Metodo de disminución de una cantidad de colorante en una solución que comprende un inhibidor de proteinasa alfa1 derivado de cultivo celular (reca1pi); metodo de purificación de a1pi humano derivado de cultivo celular de una solución acuosa que comprende reca1pi. - Google Patents
Metodo de disminución de una cantidad de colorante en una solución que comprende un inhibidor de proteinasa alfa1 derivado de cultivo celular (reca1pi); metodo de purificación de a1pi humano derivado de cultivo celular de una solución acuosa que comprende reca1pi.Info
- Publication number
- CL2013002024A1 CL2013002024A1 CL2013002024A CL2013002024A CL2013002024A1 CL 2013002024 A1 CL2013002024 A1 CL 2013002024A1 CL 2013002024 A CL2013002024 A CL 2013002024A CL 2013002024 A CL2013002024 A CL 2013002024A CL 2013002024 A1 CL2013002024 A1 CL 2013002024A1
- Authority
- CL
- Chile
- Prior art keywords
- reca1pi
- cell culture
- derived
- solution
- dye
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8125—Alpha-1-antitrypsin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
- C07K1/306—Extraction; Separation; Purification by precipitation by crystallization
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261675560P | 2012-07-25 | 2012-07-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2013002024A1 true CL2013002024A1 (es) | 2014-08-08 |
Family
ID=48748028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2013002024A CL2013002024A1 (es) | 2012-07-25 | 2013-07-11 | Metodo de disminución de una cantidad de colorante en una solución que comprende un inhibidor de proteinasa alfa1 derivado de cultivo celular (reca1pi); metodo de purificación de a1pi humano derivado de cultivo celular de una solución acuosa que comprende reca1pi. |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US9353165B2 (es) |
| EP (1) | EP2690110B1 (es) |
| JP (1) | JP6096613B2 (es) |
| KR (1) | KR101877352B1 (es) |
| CN (1) | CN103570828B (es) |
| AR (1) | AR091712A1 (es) |
| AU (1) | AU2013203772B2 (es) |
| BR (1) | BR102013016279B1 (es) |
| CA (1) | CA2821384C (es) |
| CL (1) | CL2013002024A1 (es) |
| ES (1) | ES2628914T3 (es) |
| HU (1) | HUE033582T2 (es) |
| IL (1) | IL227409A (es) |
| MX (1) | MX341733B (es) |
| MY (1) | MY161395A (es) |
| NZ (1) | NZ613080A (es) |
| PL (1) | PL2690110T3 (es) |
| PT (1) | PT2690110T (es) |
| RU (1) | RU2617960C2 (es) |
| SG (1) | SG196723A1 (es) |
| TW (1) | TWI593702B (es) |
| UY (1) | UY34915A (es) |
| ZA (1) | ZA201305247B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6783767B2 (ja) * | 2014-12-22 | 2020-11-11 | アレクシオン ファーマシューティカルズ インコーポレイテッドＡｌｅｘｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 組換えタンパク質を精製する方法 |
| AU2021225310A1 (en) * | 2020-02-25 | 2022-10-06 | Grifols Worldwide Operations Limited | Method for obtaining Alpha-1 Proteinase Inhibitor |
| KR102284800B1 (ko) * | 2020-12-30 | 2021-08-03 | 주식회사 하플사이언스 | 재조합 세포외 기질 단백질의 생산을 위한 동물세포 배양용 배지 조성물 및 이를 이용한 방법 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60186290A (ja) * | 1983-08-10 | 1985-09-21 | チモ−ジエネテイツクス インコ−ポレ−テツド | アルフア−１−アンチトリプシンを細菌に表現させる方法 |
| US4931373A (en) | 1984-05-25 | 1990-06-05 | Zymogenetics, Inc. | Stable DNA constructs for expression of α-1 antitrypsin |
| US5134119A (en) | 1990-10-16 | 1992-07-28 | Lezdey John | Treatment of inflammation using 358 substituted alpha-antitrypsin |
| US6284874B1 (en) | 1994-06-17 | 2001-09-04 | Alpha Therapeutic Corporation | Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste |
| NZ267484A (en) * | 1994-06-27 | 1997-12-19 | Ioannis Stavridis | Use of metal ion-porphyrin ring complexes in cigarette filters |
| US5616693A (en) | 1996-07-01 | 1997-04-01 | Alpha Therapeutic Corporation | Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste |
| US6093804A (en) | 1998-09-24 | 2000-07-25 | American National Red Cross | Method for purification of alpha-1 proteinase inhibitor |
| US6462180B1 (en) | 1999-11-24 | 2002-10-08 | Bayer Corporation | Method of preparing α-1 proteinase inhibitor |
| ES2543829T5 (es) | 2000-12-14 | 2023-07-13 | Grifols Therapeutics Inc | Procedimiento para la preparación del inhibidor de proteinasa alfa 1 |
| CZ20032208A3 (cs) * | 2001-02-23 | 2004-01-14 | Immunex Corporation | Zvýšený výtěžek aktivních proteinů |
| US7777006B2 (en) * | 2002-12-31 | 2010-08-17 | Csl Behring L.L.C. | Method for purification of alpha-1-antitrypsin |
| WO2005014655A2 (en) * | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
| BRPI0412835A (pt) * | 2003-08-12 | 2006-09-26 | Octapharma Ag | processo para preparação de uma solução de alfa-1-antitripsina |
| WO2005027821A2 (en) | 2003-09-22 | 2005-03-31 | Kamada Ltd. | Large scale preparation of alpha-1 proteinase inhibitor and use thereof |
| AU2004288854B2 (en) | 2003-11-10 | 2009-10-01 | Arriva-Pharmaceuticals, Inc. | Dry recombinant human alpha 1-antitrypsin formulation |
| US7807435B2 (en) * | 2005-08-11 | 2010-10-05 | Baxter International Inc. | Method for the purification of alpha-1 proteinase inhibitor (a1PI) |
| GB2446550B (en) | 2005-11-28 | 2010-12-08 | Proteomtech Inc | Methods for production of recombinant alpha1-antitrypsin |
| GB0524432D0 (en) | 2005-11-30 | 2006-01-11 | Nhs Blood & Transplant | Method |
| US8148502B2 (en) | 2006-03-30 | 2012-04-03 | Baxter International Inc. | R-ALPHA1 antitrypsin anion exchange chromatography |
| CN101778860B (zh) * | 2007-08-17 | 2013-07-10 | Csl百灵有限公司 | α-1-抗胰蛋白酶和载脂蛋白A-I的纯化方法 |
| AU2008291682B2 (en) * | 2007-08-24 | 2012-09-13 | Mylexa Pty Limited | Modulators of hypersensitivity reactions |
| PT2279265E (pt) * | 2008-04-24 | 2014-12-09 | Newsouth Innovations Pty Ltd | Agrupamento de genes saxitoxina das cianobactérias e deteção de organismos cianotoxicos |
| NZ590257A (en) | 2008-07-18 | 2012-08-31 | Grifols Therapeutics Inc | Method of preparing alpha-1 proteinase inhibitor |
| CA2756591C (en) | 2009-04-23 | 2018-11-06 | Crucell Holland B.V. | Recombinant human alpha1-antitrypsin |
| JP2011205932A (ja) * | 2010-03-29 | 2011-10-20 | Sysmex Corp | トロンビンの製造方法 |
| US8772462B2 (en) * | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| EP3412314A1 (en) * | 2011-05-27 | 2018-12-12 | Baxalta GmbH | Therapeutic proteins conjugated to polysialic acid and methods of preparing same |
-
2013
- 2013-03-14 US US13/828,374 patent/US9353165B2/en active Active
- 2013-04-11 AU AU2013203772A patent/AU2013203772B2/en active Active
- 2013-06-25 BR BR102013016279-5A patent/BR102013016279B1/pt active IP Right Grant
- 2013-07-09 KR KR1020130080176A patent/KR101877352B1/ko active IP Right Grant
- 2013-07-09 TW TW102124470A patent/TWI593702B/zh not_active IP Right Cessation
- 2013-07-09 SG SG2013052857A patent/SG196723A1/en unknown
- 2013-07-09 JP JP2013143326A patent/JP6096613B2/ja active Active
- 2013-07-10 ES ES13175879.9T patent/ES2628914T3/es active Active
- 2013-07-10 MY MYPI2013701208A patent/MY161395A/en unknown
- 2013-07-10 ZA ZA2013/05247A patent/ZA201305247B/en unknown
- 2013-07-10 IL IL227409A patent/IL227409A/en active IP Right Grant
- 2013-07-10 PT PT131758799T patent/PT2690110T/pt unknown
- 2013-07-10 HU HUE13175879A patent/HUE033582T2/hu unknown
- 2013-07-10 NZ NZ613080A patent/NZ613080A/en not_active IP Right Cessation
- 2013-07-10 EP EP13175879.9A patent/EP2690110B1/en active Active
- 2013-07-10 PL PL13175879T patent/PL2690110T3/pl unknown
- 2013-07-10 AR ARP130102440 patent/AR091712A1/es active IP Right Grant
- 2013-07-10 CA CA2821384A patent/CA2821384C/en active Active
- 2013-07-11 MX MX2013008103A patent/MX341733B/es active IP Right Grant
- 2013-07-11 CL CL2013002024A patent/CL2013002024A1/es unknown
- 2013-07-11 RU RU2013132132A patent/RU2617960C2/ru active
- 2013-07-15 CN CN201310295645.8A patent/CN103570828B/zh active Active
- 2013-07-17 UY UY0001034915A patent/UY34915A/es active IP Right Grant
-
2016
- 2016-04-26 US US15/138,682 patent/US9957315B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2015001054A1 (es) | Métodos de cultivo de microorganismos en condiciones mixotrópicas no axénicas. | |
| BRPI1011886A2 (pt) | solução contendo ácido hiplocloroso e métodos do uso do mesmo. | |
| BR112015013188A2 (pt) | método de fermentação otimizado | |
| CL2012000590A1 (es) | Proceso para preparar w-transaminasa (r)-selectiva. | |
| DK2723947T3 (da) | Centreringssystem | |
| BR112014015994A2 (pt) | processo. | |
| GB201219137D0 (en) | Direct nucleic acid amplification kit, reagent and method | |
| BR112013015496A2 (pt) | método, sistema, e, meio legível por máquina não transitório | |
| ITRM20120383A1 (it) | Metodo e kit per la rivelazione di anticorpi. | |
| BR112015008111A2 (pt) | célula de levedura geneticamente modificada, e , método para a produção de 3hp. | |
| CO6900148A2 (es) | Inhibidores de la enzima activadora de nedd8 | |
| BR112013021775A2 (pt) | bactéria corineforme, e, método para produzir um l-aminoácido | |
| CL2012002498A1 (es) | Método para extraer lípidos a partir de suspensiones acuosas de biomasa, en particular suspensiones algales desestabilizadas, usando solventes inmiscibles en agua. | |
| BR112014010195A2 (pt) | método, e, fluido | |
| SMT201700017B (it) | Combinazione, kit e metodo per ridurre la pressione intraoculare | |
| BR112016009753A2 (pt) | método de cultura de células. | |
| BR112013024363A2 (pt) | método, e aparelho | |
| BR112014007442A2 (pt) | instrumento oftalmológico, e, método | |
| BR112015014884A2 (pt) | método para identificar, polinucleotídeo isolado e kit | |
| BR112014032072A2 (pt) | método para detectar ácido nucleico e kit de detecção de ácido nucleico. | |
| DK2603612T3 (da) | Fermenteringsproces til fremstilling af kemikalier | |
| EP2757156A4 (en) | METHOD FOR PURIFYING NUCLEIC ACID, METHOD FOR EXTRACTING NUCLEIC ACID, AND KIT FOR PURIFYING NUCLEIC ACID | |
| CL2014002584A1 (es) | Método de detección de agentes infecciosos intracelulares en células espermáticas, que comprende inmunoflurescencia; y kit para llevar a cabo el método. | |
| DE102011018482A8 (de) | Medienleitung, insbesondere zum Transport von Harnstoff-Wasser-Lösungen | |
| CL2013002024A1 (es) | Metodo de disminución de una cantidad de colorante en una solución que comprende un inhibidor de proteinasa alfa1 derivado de cultivo celular (reca1pi); metodo de purificación de a1pi humano derivado de cultivo celular de una solución acuosa que comprende reca1pi. |